To this end, a high-affinity CD47 ED-silent Fc fusion protein may also be an alternative therapeutic agent to target the CD47-SIRPA axis and effectively promote macrophage-mediated tumor cell phagocytosis. The gene discussed is CD47; the disease is neoplasm.